# Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension

> **NCT01048905** · PHASE2 · COMPLETED · sponsor: **UCSF Benioff Children's Hospital Oakland** · enrollment: 13 (actual)

## Conditions studied

- Pulmonary Hypertension
- Sickle Cell Disease
- Thalassemia

## Interventions

- **DRUG:** L-Glutamine

## Key facts

- **NCT ID:** NCT01048905
- **Lead sponsor:** UCSF Benioff Children's Hospital Oakland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048905, "Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01048905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*